Molecular mechanisms of cisplatin resistance

Galluzzi, L, Senovilla, L, Vitale, I, Michels, J, Martins, I, Kepp, O, Castedo, M, Kroemer, G·2012·Oncogene
DOI 10.1038/onc.2011.384

Cited by (1,001)

Items 201–300 of 1,001

  1. The dual role of curcumin and ferulic acid in counteracting chemoresistance and cisplatin-induced ototoxicity
    Fabiola Paciello, Anna Rita Fetoni, Daniele Mezzogori, Rolando Rolesi, Antonella Di Pino, Gaetano Paludetti, Claudio Grassi, Diana Troiani · 2020 · Scientific Reports
  2. Trial Watch—Oncolytic viruses and cancer therapy
    Jonathan G. Pol, Aitziber Buqué, Fernando Aranda, Norma Bloy, Isabelle Cremer, Alexander M.M. Eggermont, Philippe Erbs, Jitka Palich Fucikova, Jérôme Galon, Jean‐Marc Limacher et al. · 2015 · OncoImmunology
  3. Inhibitor of apoptosis proteins (IAPs) mediate collagen type XI alpha 1-driven cisplatin resistance in ovarian cancer
    Miran Rada, Sameera Nallanthighal, Jennifer Cha, Kerry C. Ryan, Jessica Sage, Catherine Eldred, Maria F. Ullo, Sandra Oršulić, Dong‐Joo Cheon · 2018 · Oncogene
  4. Platinum(IV) antitumor complexes and their nano-drug delivery
    Chunyan Jia, Glen B. Deacon, Yingjie Zhang, Chuanzhu Gao · 2020 · Coordination Chemistry Reviews
  5. The Role of Tumour Metabolism in Cisplatin Resistance
    Lude Wang, Xiaoya Zhao, Jianfei Fu, Wenxia Xu, Jianlie Yuan · 2021 · Frontiers in Molecular Biosciences
  6. Platinum-Sensitive Recurrence in Ovarian Cancer: The Role of Tumor Microenvironment
    JEREMY R. CHIEN, Rui Kuang, Charles N. Landen, Viji Shridhar · 2013 · Frontiers in Oncology
  7. COL11A1 is overexpressed in recurrent non-small cell lung cancer and promotes cell proliferation, migration, invasion and drug resistance
    Lihua Shen, Min Yang, Qionghua Lin, Zhongwei Zhang, Biao Zhu, Changhong Miao · 2016 · Oncology Reports
  8. Peptide-Based Autophagic Gene and Cisplatin Co-delivery Systems Enable Improved Chemotherapy Resistance
    Yao‐Xin Lin, Yi Wang, Hong‐Wei An, Baowen Qi, Junqing Wang, Lei Wang, Jinjun Shi, Lin Mei, Hao Wang · 2019 · Nano Letters
  9. Glycosylated Platinum(IV) Complexes as Substrates for Glucose Transporters (GLUTs) and Organic Cation Transporters (OCTs) Exhibited Cancer Targeting and Human Serum Albumin Binding Properties for Drug Delivery
    Jing Ma, Qingpeng Wang, Zhong‐Lv Huang, Xiande Yang, Quandeng Nie, Wenpei Hao, Peng George Wang, Xin Wang · 2017 · Journal of Medicinal Chemistry
  10. ROS‐Responsive N‐Alkylaminoferrocenes for Cancer‐Cell‐Specific Targeting of Mitochondria
    Viktor Reshetnikov, Steffen Daum, Christina Janko, Weronika Karawacka, Rainer Tietze, Christoph Alexiou, Solomiya Ya. Paryzhak, Tetiana I. Dumych, Rostyslav O. Bilyy, Philipp Tripal et al. · 2018 · Angewandte Chemie International Edition
  11. Rising horizon in circumventing multidrug resistance in chemotherapy with nanotechnology
    Hira Choudhury, Manisha Pandey, Tan Hui Yin, Taasjir Kaur, Gan Wei Jia, S.Q. Lawrence Tan, How Weijie, Eric Koh Sze Yang, Chin Guan Keat, Subrat Kumar Bhattamisra et al. · 2019 · Materials Science and Engineering C
  12. Strategies to address key challenges of metallacycle/metallacage-based supramolecular coordination complexes in biomedical applications
    Dongdong Xu, Yang Li, Shouchun Yin, Feihe Huang · 2024 · Chemical Society Reviews
  13. TLR7 Promotes Tumor Progression, Chemotherapy Resistance, and Poor Clinical Outcomes in Non–Small Cell Lung Cancer
    Saradiya Chatterjee, Lucile Crozet, Diane Damotte, Kristina Iribarren, Catherine Schramm, Marco Alifano, Audrey Mansuet‐Lupo, Julien Cherfils‐Vicini, Jérémy Goc, Sandrine Katsahian et al. · 2014 · Cancer Research
  14. Syntheses, Characterizations, and a Preliminary Comparative Cytotoxicity Study of Gold(I) and Gold(III) Complexes Bearing Benzimidazole- and Pyrazole-Derived N-Heterocyclic Carbenes
    Haresh Sivaram, Jackie Tan, Han Vinh Huynh · 2012 · Organometallics
  15. Graphene quantum dots enhance anticancer activity of cisplatin via increasing its cellular and nuclear uptake
    Xin Sui, Chao Luo, Chong Wang, Fangwei Zhang, Jingyan Zhang, Shouwu Guo · 2016 · Nanomedicine Nanotechnology Biology and Medicine
  16. Epigenetic drugs in cancer therapy
    Amila Suraweera, Kenneth John O'Byrne, Derek J. Richard · 2025 · Cancer and Metastasis Reviews
  17. Recent Advances in Platinum (IV) Complex‐Based Delivery Systems to Improve Platinum (II) Anticancer Therapy
    Xiaopeng Han, Jin Sun, Yongjun Wang, Zhonggui He · 2015 · Medicinal Research Reviews
  18. Characterization of Hydrophilic Gold(I) N-Heterocyclic Carbene (NHC) Complexes as Potent TrxR Inhibitors Using Biochemical and Mass Spectrometric Approaches
    Özden Karaca, Valeria Scalcon, Samuel M. Meier, Riccardo Bonsignore, J. Brouwer, Federica Tonolo, Alessandra Folda, Maria Pia Rigobello, Fritz E. Kühn, Angela Casini · 2017 · Inorganic Chemistry
  19. Non-apoptotic cell death in malignant tumor cells and natural compounds
    Jing Ye, Ruonan Zhang, Fan Wu, Lijuan Zhai, Kaifeng Wang, Mang Xiao, Tian Xie, Xinbing Sui · 2018 · Cancer Letters
  20. Nrf2 induces cisplatin resistance through activation of autophagy in ovarian carcinoma.
    Ling-Jie Bao, Melba C. Jaramillo, Zhen-Bo Zhang, Yun-Xi Zheng, Ming Yao, Donna D. Zhang, Xiao-Fang Yi · 2014 · Europe PMC (PubMed Central)
  21. Cancer therapeutic strategies based on metal ions
    Yang Liu, Yinghui Wang, Shuyan Song, Hongjie Zhang · 2021 · Chemical Science
  22. Identification and characterization of cancer stem cells in human head and neck squamous cell carcinoma
    Jing Han, Toshio Fujisawa, Syed Rafat Husain, Raj K. Puri · 2014 · BMC Cancer
  23. Intracellular glutathione-depleting polymeric micelles for cisplatin prodrug delivery to overcome cisplatin resistance of cancers
    Yu Han, Wei Yin, Junjie Li, Hong Liang Zhao, Zengshi Zha, Wendong Ke, Yuheng Wang, Chuanxin He, Zhishen Ge · 2018 · Journal of Controlled Release
  24. Combination therapy: Histone deacetylase inhibitors and platinum-based chemotherapeutics for cancer
    H.V.K. Diyabalanage, Michael L. Granda, Jacob M. Hooker · 2012 · Cancer Letters
  25. Novel combination of mitochondrial division inhibitor 1 (mdivi-1) and platinum agents produces synergistic pro-apoptotic effect in drug resistant tumor cells
    Wei Qian, Jingnan Wang, Vera Y. Roginskaya, Lee A. McDermott, Robert P. Edwards, Donna Beer Stolz, Fabien Llambi, Douglas R. Green, Bennett Van Houten · 2014 · Oncotarget
  26. Exosome-Mediated Transfer of lncRNA HOTTIP Promotes Cisplatin Resistance in Gastric Cancer Cells by Regulating HMGA1/miR-218 Axis
    Jingyu Wang, Baojun Lv, Yonghui Su, Xiao Wang, Juyuan Bu, Lan Yao · 2019 · OncoTargets and Therapy
  27. Human Helicase RECQL4 Drives Cisplatin Resistance in Gastric Cancer by Activating an AKT–YB1–MDR1 Signaling Pathway
    Dongliang Mo, Hongbo Fang, Kaifeng Niu, Jing Liu, Meng Yao Wu, Shiyou Li, Tienian Zhu, Mohammed A. Aleskandarany, Arvind Arora, Dileep N. Lobo et al. · 2016 · Cancer Research
  28. EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary Cancer
    Xuemin Wang, Pan Jiang, Pengqi Wang, Chung Shu Yang, Xuerong Wang, Qing Feng · 2015 · PLoS ONE
  29. A covalently bound inhibitor triggers EZH2 degradation through CHIP‐mediated ubiquitination
    Xu Wang, Wei Cao, Jianjun Zhang, Ming Yan, Qin Xu, Xiangbing Wu, Lixin Wan, Zhiyuan Zhang, Chenping Zhang, Xing Qin et al. · 2017 · The EMBO Journal
  30. Nitric Oxide Generated by Tumor-Associated Macrophages Is Responsible for Cancer Resistance to Cisplatin and Correlated With Syntaxin 4 and Acid Sphingomyelinase Inhibition
    Cristiana Perrotta, Davide Cervia, Ilaria Di Renzo, Claudia Moscheni, Maria Teresa Bassi, Lara Campana, Cristina Martelli, Elisabetta Catalani, Matteo Giovarelli, Silvia Zecchini et al. · 2018 · Frontiers in Immunology
  31. Differing Roles of Hyaluronan Molecular Weight on Cancer Cell Behavior and Chemotherapy Resistance
    Zoe K. Price, Noor A. Lokman, Carmela Ricciardelli · 2018 · Cancers
  32. Long-Term Lysosomes Tracking with a Water-Soluble Two-Photon Phosphorescent Iridium(III) Complex
    Kangqiang Qiu, Huaiyi Huang, Bingyang Liu, Yukang Liu, Ziyi Huang, Yu Chen, Liang‐Nian Ji, Hui Chao · 2016 · ACS Applied Materials & Interfaces
  33. Inhibition of 6-phosphogluconate Dehydrogenase Reverses Cisplatin Resistance in Ovarian and Lung Cancer
    Wujian Zheng, Qi Feng, Jiao Liu, Yanke Guo, Lvfen Gao, Ruiman Li, Meng Xu, Guizhen Yan, Zhinan Yin, Shuai Zhang et al. · 2017 · Frontiers in Pharmacology
  34. Necroptosis-Inducing Rhenium(V) Oxo Complexes
    Kogularamanan Suntharalingam, Samuel G. Awuah, Peter M. Bruno, Timothy C. Johnstone, Fang Wang, Lin Wei, Yao‐Rong Zheng, Julia E. Page, Michael T. Hemann, Stephen J. Lippard · 2015 · Journal of the American Chemical Society
  35. Organotin(IV)‐Loaded Mesoporous Silica as a Biocompatible Strategy in Cancer Treatment
    Mirna Bulatović, Danijela Maksimović‐Ivanić, Christian Bensing, Santiago Gómez‐Ruiz, Dirk Steinborn, Harry Schmidt, Marija Mojić, Aleksandra Korać, Igor Golić, Damián Pérez‐Quintanilla et al. · 2014 · Angewandte Chemie International Edition
  36. Polysaccharide from Lentinus edodes combined with oxaliplatin possesses the synergy and attenuation effect in hepatocellular carcinoma
    Yu Zhang, Qiang Li, Junfeng Wang, Fang Cheng, Xiao Huang, Yao Cheng, Kaiping Wang · 2016 · Cancer Letters
  37. MicroRNA-218 Increases the Sensitivity of Bladder Cancer to Cisplatin by Targeting Glut1
    Peng Li, Xiao Feng Yang, Yidong Cheng, Xiaolei Zhang, Chengdi Yang, Xiaheng Deng, Pengchao Li, Jun Tao, Haiwei Yang, Jifu Wei et al. · 2017 · Cellular Physiology and Biochemistry
  38. Activity and Trafficking of Copper-Transporting ATPases in Tumor Development and Defense against Platinum-Based Drugs
    Raffaella Petruzzelli, Roman Polishchuk · 2019 · Cells
  39. Circular RNA MCTP2 inhibits cisplatin resistance in gastric cancer by miR-99a-5p-mediated induction of MTMR3 expression
    Guangli Sun, Zheng Li, Zhongyuan He, Weizhi Wang, Sen Wang, Xing Zhang, Jiacheng Cao, Penghui Xu, Haixiao Wang, Xiaoxu Huang et al. · 2020 · Journal of Experimental & Clinical Cancer Research
  40. Integrated Genomic Analysis Identifies Driver Genes and Cisplatin-Resistant Progenitor Phenotype in Pediatric Liver Cancer
    Théo Z. Hirsch, Jill Pilet, Guillaume Morcrette, Amélie Roehrig, Benedict J.E. Monteiro, Laura Maria Molina, Quentin Bayard, Eric Trépo, Léa Meunier, Stefano Caruso et al. · 2021 · Cancer Discovery
  41. Anti-cancer & anti-metastasis properties of bioorganic-capped silver nanoparticles fabricated from Juniperus chinensis extract against lung cancer cells
    Hassan Noorbazargan, Sobhan amintehrani, Aghigh Dolatabadi, Ainaz Mashayekhi, Nazanin Khayam, Pooria Moulavi, Mohammad Naghizadeh, Amir Mirzaie, Fatmeh Mirzaei rad, Mahsa Kavousi · 2021 · AMB Express
  42. Altered glutamine metabolism in platinum resistant ovarian cancer
    Chantelle D. Hudson, Alyssa Savadelis, Anil Belur Nagaraj, Peronne L. Joseph, Stefanie Avril, Analisa V. DiFeo, Norbert E. Avril · 2016 · Oncotarget
  43. Exosomal DNMT1 mediates cisplatin resistance in ovarian cancer
    Yalei Cao, Ting Zhuang, Bao‐Heng Xing, Na Li, Qin Li · 2017 · Cell Biochemistry and Function
  44. Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38
    Katharina Gohr, Alexandra Hamacher, Laura H. Engelke, Matthias Ulrich Kassack · 2017 · BMC Cancer
  45. A view on multi-action Pt(IV) antitumor prodrugs
    Mauro Ravera, Elisabetta Gabano, Michael J. McGlinchey, Domenico Osella · 2019 · Inorganica Chimica Acta
  46. Trial Watch:
    Jonathan G. Pol, Norma Bloy, Florine Obrist, Alexander M.M. Eggermont, Jérôme Galon, Isabelle Cremer, Philippe Erbs, Jean‐Marc Limacher, Xavier Préville, Laurence Zitvogel et al. · 2014 · OncoImmunology
  47. Cellular landscaping of cisplatin resistance in cervical cancer
    Bhattacharjee, Rahul, Dey, Tanima, Kumar, Lamha, Kar, Sulagna, Sarkar, Ritayan, Ghorai, Mimosa, Malik, Sumira, Jha, Niraj Kumar, Vellingiri, Balachandar, Kesari, Kavindra Kumar et al. · 2022 · Biomedicine & Pharmacotherapy
  48. miR-205 impairs the autophagic flux and enhances cisplatin cytotoxicity in castration-resistant prostate cancer cells
    Marzia Pennati, Alessia Lopergolo, Valentina Profumo, Michelandrea De Cesare, Stefania Sbarra, R. Valdagni, Nadia Zaffaroni, Paolo Gandellini, Marco Folini · 2013 · Biochemical Pharmacology
  49. Gene expression profiling of single circulating tumor cells in ovarian cancer – Establishment of a multi‐marker gene panel
    Christina Blassl, Jan Dominik Kuhlmann, Alessandra Webers, Pauline Wimberger, Tanja Natascha Fehm, Hans J. Neubauer · 2016 · Molecular Oncology
  50. Berberine in combination with cisplatin suppresses breast cancer cell growth through induction of DNA breaks and caspase-3-dependent apoptosis
    Yuwan Zhao, Zuolei Jing, Yan Li, Weifeng Mao · 2016 · Oncology Reports
  51. MiR-129 regulates cisplatin-resistance in human gastric cancer cells by targeting P-gp
    Chaojing Lu, Zhengxiang Shan, Chunguang Li, Lixin Yang · 2016 · Biomedicine & Pharmacotherapy
  52. STAT3/NF-κB-Regulated Lentiviral TK/GCV Suicide Gene Therapy for Cisplatin-Resistant Triple-Negative Breast Cancer
    Wei-Ying Kuo, Luen Hwu, Chun-Yi Wu, Jhih-Shian Lee, Chi‐Wei Chang, Ren-Shyan Liu · 2017 · Theranostics
  53. Platinum(IV) Prodrugs with Haloacetato Ligands in the Axial Positions can Undergo Hydrolysis under Biologically Relevant Conditions
    Ezequiel Wexselblatt, Eylon Yavin, Dan Gibson · 2013 · Angewandte Chemie International Edition
  54. Overcoming the road blocks: advancement of block copolymer micelles for cancer therapy in the clinic
    Houdaihed, Loujin, Evans, James C., Allen, Christine · 2017 · Molecular Pharmaceutics
  55. The mitochondrial permeability transition pore and its adaptive responses in tumor cells
    Andrea Rasola, Paolo Bernardi · 2014 · Cell Calcium
  56. Trial Watch
    Erika Vacchelli, Ilio Vitale, Éric Tartour, Alexander M.M. Eggermont, Catherine Sautès‐Fridman, Jérôme Galon, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi · 2013 · OncoImmunology
  57. Advances in diagnosis and treatment of testicular cancer
    Michal Chovanec, Liang Cheng C · 2022 · BMJ
  58. Paradoxical action of reactive oxygen species in creation and therapy of cancer
    Sina Kardeh, Soheil Ashkani‐Esfahani, Ali Mohammad Alizadeh · 2014 · European Journal of Pharmacology
  59. Mitochondria-Localized Fluorescent BODIPY-Platinum Conjugate
    Tingting Sun, Xingang Guan, Min Jing Zheng, Xiabin Jing, Zhigang Xie · 2015 · ACS Medicinal Chemistry Letters
  60. Erastin synergizes with cisplatin via ferroptosis to inhibit ovarian cancer growth in vitro and in vivo
    Qi Cheng, Lingjie Bao, Ming‐Qing Li, Kai‐Kai Chang, Xiaofang Yi · 2021 · Journal of obstetrics and gynaecology research
  61. Small Molecule Inhibitors of ERCC1-XPF Protein-Protein Interaction Synergize Alkylating Agents in Cancer Cells
    Lars Petter Jordheim, Khaled Barakat, Laurence Heinrich, Eva‐Laure Matera, Emeline Cros‐Perrial, Karima Bouledrak, Rana El Sabeh, Rolando Pérez, David Scott Wishart, Richard Cohen et al. · 2013 · Molecular Pharmacology
  62. Immune-dependent antineoplastic effects of cisplatin plus pyridoxine in non-small-cell lung cancer
    Aranda, F, Bloy, N, Pesquet, J, Petit, B, Chaba, K, Sauvat, A, Kepp, O, Khadra, N, Enot, D, Pfirschke, C et al. · 2015 · Oncogene
  63. Olaparib modulates DNA repair efficiency, sensitizes cervical cancer cells to cisplatin and exhibits anti-metastatic property
    Prasad, Chandra Bhushan, Prasad, Shyam Babu, Yadav, Suresh Singh, Pandey, Laxmi Kant, Singh, Sunita, Pradhan, Satyajit, Narayan, Gopeshwar · 2017 · Scientific Reports
  64. Recent Considerations in the Application of RAPTA‐C for Cancer Treatment and Perspectives for Its Combination with Immunotherapies
    Magdalena Rausch, Paul J. Dyson, Patrycja M. Nowak-Sliwinska · 2019 · Advanced Therapeutics
  65. The Self-Assembly of a Cyclometalated Palladium Photosensitizer into Protein-Stabilized Nanorods Triggers Drug Uptake In Vitro and In Vivo
    Xue‐Quan Zhou, Ming Xiao, Vadde Ramu, Jonathan Hilgendorf, Xuezhao Li, Panagiota Papadopoulou, Maxime A. Siegler, Alexander Kros, Wen Ce Sun, Sylvestre A. Bonnet · 2020 · Journal of the American Chemical Society
  66. Interference between copper transport systems and platinum drugs
    Fabio Arnesano, Giovanni Natile · 2021 · Seminars in Cancer Biology
  67. Single‐Cell Quantification of a Highly Biocompatible Dinuclear Iridium(III) Complex for Photocatalytic Cancer Therapy
    Zhongxian Fan, Yi Rong, Tumpa Sadhukhan, Shaoxia Liang, Wenqing Li, Zhanxiang Yuan, Zilin Zhu, Shunwen Guo, Shaomin Ji, Jinquan Wang et al. · 2022 · Angewandte Chemie International Edition
  68. Cisplatin Resistance: Genetic and Epigenetic Factors Involved
    Yuliannis Lugones, Pía Loren, Luis Antonio Salazar · 2022 · Biomolecules
  69. Ferroptosis in lung cancer: a novel pathway regulating cell death and a promising target for drug therapy
    Nan Xing, Qinyun Du, Sa Guo, Gelin Xiang, Yi Zhang, Xianli Meng, Xiang Li, Shaohui Wang · 2023 · Cell Death Discovery
  70. Inhibition of Gpx4-mediated ferroptosis alleviates cisplatin-induced hearing loss in C57BL/6 mice
    Ziyi Liu, Hanbing Zhang, Guodong Hong, Xiuli Bi, Jun Hu, Tiancheng Zhang, Yachun An, Na Guo, Fengyue Dong, Yu Xiao et al. · 2024 · Molecular Therapy
  71. Beclin-1: a therapeutic target at the intersection of autophagy, immunotherapy, and cancer treatment
    Zhumin Cao, Ke Tian, Yincheng Ran, Haonan Zhou, Lei Zhou, Yana Ding, Xiaowei Tang · 2024 · Frontiers in Immunology
  72. Combined chemotherapy and photodynamic therapy using a nanohybrid based on layered double hydroxides to conquer cisplatin resistance
    Zhigang Wang, Rong Ma, Li Yan, Xianfeng Chen, Guangyu Zhu · 2015 · Chemical Communications
  73. Synthesis of α,β-Unsaturated Carbonyl-Based Compounds, Oxime and Oxime Ether Analogs as Potential Anticancer Agents for Overcoming Cancer Multidrug Resistance by Modulation of Efflux Pumps in Tumor Cells
    Hua‐Li Qin, Jing Leng, Cheng‐Pan Zhang, Ibrahim Jantan, Muhammad Wahab Amjad, Muhammad Sher, Muhammad Naeem ul Hassan, Muhammad Ajaz Hussain, Syed Nasir Abbas Bukhari · 2016 · Journal of Medicinal Chemistry
  74. Autophagy inhibitor chloroquine increases sensitivity to cisplatin in QBC939 cholangiocarcinoma cells by mitochondrial ROS
    Xianzhi Qu, Jiyao Sheng, Luyan Shen, Jing Su, Yunjie Xu, Qi Xie, Wu Yao, Xuewen Zhang, Liankun Sun · 2017 · PLoS ONE
  75. miR-483-5p determines mitochondrial fission and cisplatin sensitivity in tongue squamous cell carcinoma by targeting FIS1
    Song Fan, Wei-Xiong Chen, Xiaobin Lv, Qiong-Lan Tang, Lijuan Sun, Bodu Liu, Jianglong Zhong, Zhaoyu Lin, Youyuan Wang, Qunxing Li et al. · 2015 · Cancer Letters
  76. Scutellarin Increases Cisplatin-Induced Apoptosis and Autophagy to Overcome Cisplatin Resistance in Non-small Cell Lung Cancer via ERK/p53 and c-met/AKT Signaling Pathways
    Chao‐Yue Sun, Ying Zhu, Xiaofeng Li, Xieqi Wang, Lipeng Tang, Zuqing Su, Caiyun Li, Guangjuan Zheng, Bing Feng · 2018 · Frontiers in Pharmacology
  77. Characterization of a novel HDAC/RXR/HtrA1 signaling axis as a novel target to overcome cisplatin resistance in human non-small cell lung cancer
    Wenjing Wang, Mengyue Zhao, Lijuan Cui, Yong Ren, Jingyuan Zhang, Junli Chen, Lina Jia, Jiayu Zhang, Jingyu Yang, Guoliang Chen et al. · 2020 · Molecular Cancer
  78. Necroptosis: A new way of dying?
    Britt Hanson · 2016 · Cancer Biology & Therapy
  79. Exploiting the acquired vulnerability of cisplatin-resistant tumors with a hypoxia-amplifying DNA repair–inhibiting (HYDRI) nanomedicine
    Jing Chen, Xue Wang, Yuan Yuan, Haoting Chen, Lingpu Zhang, Haihua Xiao, Jingqi Chen, Yongxiang Zhao, Jin Keun Chang, Weisheng Guo et al. · 2021 · Science Advances
  80. Targeting miRNAs and Other Non-Coding RNAs as a Therapeutic Approach: An Update
    Emine Bayraktar, Recep Bayraktar, Hülya Öztatlıcı, Gabriel Lopez‐Berestein, Paola Amero, Cristian Rodriguez‐Aguayo · 2023 · Non-Coding RNA
  81. Apigenin enhances the cisplatin cytotoxic effect through p53-modulated apoptosis
    Rui Liu, Ping Ji, Bin Liu, Haishi Qiao, Xia Wang, Likun Zhou, Ting Deng, Yi Ba · 2016 · Oncology Letters
  82. In‐Cell Activation of Organo‐Osmium(II) Anticancer Complexes
    Russell J. Needham, Carlos Sánchez-Cano, Xin Zhang, Isolda Romero‐Canelón, Abraha Habtemariam, Margaret S. Cooper, Levente K. Meszaros, Guy J. Clarkson, Philip J. Blower, Peter John Sadler · 2016 · Angewandte Chemie International Edition
  83. Control of Oxidative Stress in Cancer Chemoresistance: Spotlight on Nrf2 Role
    Giuseppina Barrera, Marie Angèle Cucci, Margherita Grattarola, Chiara Dianzani, Giuliana Muzio, Stefania Pizzimenti · 2021 · Antioxidants
  84. TXNL1-XRCC1 pathway regulates cisplatin-induced cell death and contributes to resistance in human gastric cancer
    Wei Xu, S Wang, Qi Chen, Yao Zhang, Peidong Ni, Xuming Wu, Junjie Zhang, Fulin Qiang, Ao Li, Oluf Dimitri Røe et al. · 2014 · Cell Death and Disease
  85. Comparative Cytotoxicity of Artemisinin and Cisplatin and Their Interactions with Chlorogenic Acids in MCF7 Breast Cancer Cells
    John Suberu, Isolda Romero‐Canelón, Neil Sullivan, Alexei A. Lapkin, Guy C. Barker · 2014 · ChemMedChem
  86. A metabolomic approach to identifying platinum resistance in ovarian cancer
    Laila Poisson, Adnan R. Munkarah, Hala Madi, Indrani Datta, Sharon Hensley-Alford, Calvin Tebbe, Thomas Buekers, Shailendra Giri, Ramandeep Rattan · 2015 · Journal of Ovarian Research
  87. HDAC Inhibitors: Dissecting Mechanisms of Action to Counter Tumor Heterogeneity
    Dimitris Karagiannis, Theodoros N Rampias · 2021 · Cancers
  88. Can Cisplatin Therapy Be Improved? Pathways That Can Be Targeted
    Reem Ali, Mustapha Aouida, Abdallah Alhaj Sulaiman, Srinivasan Madhusudan, Dindial Ramotar · 2022 · International Journal of Molecular Sciences
  89. FOXM1 Modulates Cisplatin Sensitivity by Regulating EXO1 in Ovarian Cancer
    Jinhua Zhou, Yunfei Wang, You Wang, Xia Yin, Yifeng He, Lilan Chen, Wenwen Wang, Ting Liu, Wen J. Di · 2014 · PLoS ONE
  90. Aquaporin 3 facilitates chemoresistance in gastric cancer cells to cisplatin via autophagy
    Xuqiang Dong, Yao Wang, Yangchun Zhou, Jianfei Wen, Shoulin Wang, Lizong Shen · 2016 · Cell Death Discovery
  91. DUSP16 promotes cancer chemoresistance through regulation of mitochondria-mediated cell death
    Heng Boon Low, Zhen Lim Wong, Bangyuan Wu, Li Ren Kong, Chin Wen Png, Yik-Lam Cho, Chunwei Li, Fengchun Xiao, Xuan Xin, Henry He Yang et al. · 2021 · Nature Communications
  92. Substrate Stiffness Modulates the Growth, Phenotype, and Chemoresistance of Ovarian Cancer Cells
    Yali Fan, Quanmei Sun, Xia Li, Jiantao Feng, Zhuo Ao, Xiang Li, Jiandong Wang · 2021 · Frontiers in Cell and Developmental Biology
  93. Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics
    M. Ferraro, Marialuisa Piccolo, G. Misso, Rita Santamaria, Carlo Irace · 2022 · Pharmaceutics
  94. Advances of antitumor drug discovery in traditional Chinese medicine and natural active products by using multi‐active components combination
    Wei Hua Zhao, Xiao‐Di Zheng, Paula Yun‐Zhi Tang, Hongmei Li, Xue Liu, Jian‐Jiang Zhong, Ya-jie Tang A · 2023 · Medicinal Research Reviews
  95. Synergistic cytotoxic action of cisplatin and withaferin A on ovarian cancer cell lines
    Sham S. Kakar, Venkatakrishna Rao Jala, Miranda Fong · 2012 · Biochemical and Biophysical Research Communications
  96. Antitumor drug delivery in multicellular spheroids by electropermeabilization
    Laure Gibot, Luc Wasungu, Justin Teissié, Marie‐Pierre Rols · 2013 · Journal of Controlled Release
  97. Cyclodextrin-based delivery systems for in vivo-tested anticancer therapies
    Ana Cláudia Paiva‐Santos, Diana Costa, Laura Ferreira, Catarina Guerra, Miguel Pereira‐Silva, Irina Pereira, Diana Peixoto, Nuno R. Ferreira, Francisco Veiga · 2020 · Drug Delivery and Translational Research
  98. Platinum-Based Combination Therapy: Molecular Rationale, Current Clinical Uses, and Future Perspectives
    Chunqiu Yu, Zhibin Wang, Zeren Sun, Lei Zhang, Wanwan Zhang, Yungen Xu, Jing‐Jing Zhang · 2020 · Journal of Medicinal Chemistry
  99. Silence of fibronectin 1 increases cisplatin sensitivity of non-small cell lung cancer cell line
    Weiwei Gao, Ying Liu, Ruiling Qin, Daijian Liu, Qingqing Feng · 2016 · Biochemical and Biophysical Research Communications
  100. Lysosomal Targeting with Stable and Sensitive Fluorescent Probes (Superior LysoProbes): Applications for Lysosome Labeling and Tracking during Apoptosis
    Xin Chen, Yue Bi, Tianyang Wang, Pengfei Li, Xin Yan, Shanshan Hou, Catherine E. Bammert, Jingfang Ju, K. Michael Gibson, William J. Pavan et al. · 2015 · Scientific Reports